insitro is a biotechnology company that uses machine learning and large-scale data to accelerate the discovery and development of new medicines. The company develops a robust platform and pipeline to decode biological complexity and identify therapeutic insights, focusing on metabolism, oncology, and neuroscience. Based in the San Francisco Bay Area, insitro aims to bring better drugs faster to patients by integrating in vitro data with human clinical data to guide drug discovery and development.
No recent news for this company.
No recent deals for this company.